[Chromomycosis. Treatment with a combination of thiabendazole and 5-fluorocytosine, 6-year follow-up]. 1983

E Solano, and H Hidalgo, and A Castro, and F Montero-Gei

The results of the treatment of 30 cases of chromomycosis (fonsecal pedrosoi) with Thiabendazole (1 g.) and 5. Fluorocytosine (4 g.) are reported. The medium rate of healing was 7,63 months. This treatment was effective in 25 of 30 cases (83 por 100) and ono-effective in 3 (10 por 100). In 2 cases recurrences occurred (6,66 por 100).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002862 Chromoblastomycosis Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p362) Chromomycosis,Dermatitis Verrucosa,Chromoblastomycoses,Chromomycoses
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005437 Flucytosine A fluorinated cytosine analog that is used as an antifungal agent. 5-Fluorocytosine,Alcobon,Ancobon,Ancotil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
December 1985, The Ceylon medical journal,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
January 1985, Annales de la Societe belge de medecine tropicale,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
January 1971, International journal of dermatology,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
February 1979, Journal of cutaneous pathology,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
February 1983, Journal of the American Academy of Dermatology,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
January 1979, Medicina cutanea ibero-latino-americana,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
November 1971, Archives of dermatology,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
February 1977, The Journal of dermatology,
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
April 1969, Hospital (Rio de Janeiro, Brazil),
E Solano, and H Hidalgo, and A Castro, and F Montero-Gei
December 1974, The British journal of dermatology,
Copied contents to your clipboard!